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Abstract
Several Acinetobacter strains have utility for biotechnology applications, yet some are opportunistic pathogens. We
compared strains of seven Acinetobacter species (baumannii, Ab; calcoaceticus, Ac; guillouiae, Ag; haemolyticus, Ah; lwoffii, Al;
junii, Aj; and venetianus, Av-RAG-1) for their potential virulence attributes, including proliferation in mammalian cell
conditions, haemolytic/cytolytic activity, ability to elicit inflammatory signals, and antibiotic susceptibility. Only Ah grew at
10
2 and 10
4 bacteria/well in mammalian cell culture medium at 37uC. However, co-culture with colonic epithelial cells (HT29)
improved growth of all bacterial strains, except Av-RAG-1. Cytotoxicity of Ab and Ah toward HT29 was at least double that
of other test bacteria. These effects included bacterial adherence, loss of metabolism, substrate detachment, and cytolysis.
Only Ab and Ah exhibited resistance to killing by macrophage-like J774A.1 cells. Haemolytic activity of Ah and Av-RAG-1
was strong, but undetectable for other strains. When killed with an antibiotic, Ab, Ah, Aj and Av-RAG-1 induced 3 to 9-fold
elevated HT29 interleukin (IL)-8 levels. However, none of the strains altered levels of J774A.1 pro-inflammatory cytokines (IL-
1b, IL-6 and tumor necrosis factor-a). Antibiotic susceptibility profiling showed that Ab, Ag and Aj were viable at low
concentrations of some antibiotics. All strains were positive for virulence factor genes ompA and epsA, and negative for
mutations in gyrA and parC genes that convey fluoroquinolone resistance. The data demonstrate that Av-RAG-1, Ag and Al
lack some potentially harmful characteristics compared to other Acinetobacter strains tested, but the biotechnology
candidate Av-RAG-1 should be scrutinized further prior to widespread use.
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Introduction
The genus Acinetobacter comprises 27 known species and several
unnamed provisional species of gram-negative, ubiquitous, non-
motile, non-fermentative, coccobacilli [1–2]. Many members share
phenotypic features, but are not well defined with respect to
beneficial and harmful characteristics [3].
In recent years, certain strains of different Acinetobacter species
have been developed for bioremediation of recalcitrant and
harmful organic chemicals, as well as bioengineering of enzymes
and diagnostic materials [4–8]. One promising example is the
RAG-1 strain of A. venetianus, which has been shown to produce
several oil-modifying substances such as emulsans, esterases,
lipases and surfactants [9–11]. This strain was previously assigned
to other species groups (A.calcoaceticus and A.lwoffi) [12] which are
recognized as opportunistic pathogens. Further advancement of
the Acinetobacter genus for beneficial applications requires a rigorous
clarification concerning threats to drinking water [13–14] and
linkages to nosocomial infections [15–20].
Clinically, A.baumannii (Ab) is most often identified as the cause
of infection, but others include A.calcoaceticus (Ac), A.haemolyticus
(Ah), A.lwoffii (Al) and A.junii (Aj) [20–26]. The majority of reported
clinical cases involved pneumonia/pulmonary infections and
septicaemia, but others included endocarditis, meningitis, burn
and surgical wound infections, and urinary tract infections. Many
clinical isolates have acquired multiple antibiotic resistance
[27][17] and can be more pan-resistant than even methicillin-
resistant Staphylococcus aureus (MRSA) [28]. Furthermore, infections
caused by Acinetobacter are not restricted to the clinical setting, and
reports have emerged describing cases involving otherwise healthy
individuals of varying ages, occurring in community settings,
during wars, and following natural disasters [29–36].
To date there has been no comparative testing for potential
virulence and toxic effects of Acinetobacter species/strains isolated
from clinical and environmental sources, which should be
necessary prior to any intended biotechnology application. Our
research objective is to expand the repertoire of useful endpoints
required to predict and rank pathogenicity potential of environ-
mental Acinetobacter strains with the aim of reducing the use of more
costly and laborious in vivo test methods. In previous work, we
developed a set of pathogenicity-toxicity parameters that could
differentiate between potentially harmful and non-toxic strains of
Bacillus species [37–39]. Here we describe a side-by-side compar-
ison of strains from seven Acinetobacter strains which were selected
from both clinical and environmental sources (See Table 1). We
used our previous test parameters, as well as others developed to
study clinical Acinetobacter strains. The latter include assays which
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disrupt mammalian cell interactions (attachments) [41–42][44–
49], produce haemolytic or cytolytic activities [41][50–51], and/or
infect by way of proliferation in mammalian cell culture medium.
Also included is an assessment of exposure-induced immune
system responses such as release of pro-inflammatory cytokines
and chemoattractants (interleukin (IL)-1b, IL-6, IL-8, and tumour
necrosis factor-a (TNF-a)), as observed in vitro with laryngeal
epithelial cells [48] and cultured mouse splenocytes [52].
Materials and Methods
Bacterial Culture and Monitoring
Table 1 contains a list of the bacteria used in this study, along
with their acquisition sources, species abbreviations, and biohaz-
ard ranking as designated by ATCC. Strains were selected based
on availability from known repositories (ATCC), and quantity of
literature information on the each strain. Almost all strains selected
were Type Strains (except Ab ATCC# 9955), although this was
not part of the selection criteria. In all experiments, level two
biosafety facility and procedures were used. Bacterial stocks were
adjusted to10
8 cfu/mL, stored at 280uC and routinely checked
for viability, morphology and homogeneity by plating on Luria-
Bertani (LB)-agar. For assessment of Ag growth, nutrient broth
(NB) plates were used, which permitted more rapid results
compared to LB plates. Growth of bacteria was assessed at 28uC
and 37uC with turbidity measurements (optical density at 450 nm
(OD450)) over a 24 h period using an automated scanning
multiwell spectrophotometer (Spectramax Plus 386, Molecular
Devices Co., Sunnyvale CA). Additional monitoring for growth
and viability of cultures was done by measuring bioreduction
activity after incubating cultures with 0.5 mg/mL XTT (sodium
39-{1-[(phenylamino)-carbonyl]-3,4-tetrazolium}-bis{4-methoxy-
6-nitro} benzene sulphonic acid hydrate), as done previously with
Bacillus organisms [53]. Bacterial reduction of the tetrazolium salt
XTT to XTT formazan was measured at OD480 every 15 min.
Cell-free bacterial culture filtrates were prepared by inoculating
10 mL of nutrient broth with 10
8 cfu of bacteria. Following 24 h
at 28uCo r3 7 uC, cultures were centrifuged at 12,0006G and the
supernatants were filtered through a 0.22 mm syringe filter
(Millipore Corp, Bedford, MA).
Bacterial Antibiotic Susceptibility and Haemolytic Activity
The Minimal Inhibitory Concentration (MIC) assay was
conducted as described by Seligy and Rancourt [54]. Antibiotics
were purchased from the Sigma Chemical Company (Oakville,
ON) and Invitrogen (Carlsbad, CA). Using 96-multi-well plates,
2610
4 cfu of bacteria were added to each microwell containing an
antibiotic dilution series in trypticase soy broth (TSB) (200 mL final
volume). The final concentration of each antibiotic in the series
was 24, 12, 6, 3, 1.5, 0.75, 0.38 and zero mg/ml. Since growth in
TSB varied between strains, plates were incubated at 28uCo r
37uC for 24 h, 48 h or 96 h to generate enough bacterial growth
to evaluate antibiotic susceptibility. The bacterial metabolic status
of each sample was determined by adding MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) to a final
concentration of one mg/ml/well. Plates were then incubated at
28uCo r3 7 uC for two hours and examined for purple crystals. The
MIC was defined as the minimum antibiotic concentration
resulting in no detectable MTT bioreduction, which indicates
that no metabolic activity and proliferation of bacterial cells has
occurred.
Haemolytic activity produced by various Acinetobacter strains was
compared to that produced by the positive control (Bacillus cereus
ATCC# 14579). Sterile, defibrinated sheep blood (Cedarlane
Laboratories, Hornby, Ontario) was washed three times with PBS
by repeated centrifugation and resuspension in 0.9% (w/v) saline,
before resuspension at a final concentration of 5% (v/v) with
cooled (45uC), autoclaved agar (1.2% (w/v)) containing 1.4% (w/
v) pancreatic digest of casein, 0.5% (w/v) NaCl, 0.45% (w/v)
peptone and 0.45% (w/v) yeast extract. After agar solidification,
each strain was deposited (10
3 cfu/10 mL spot) in a grid pattern
onto the surface, and incubated at 37uC for up to 6 days.
Photographs were taken daily to monitor haemolytic progression.
Mammalian Cell Culture and Exposures
Human HT29 colonic epithelial cells and mouse J774A.1
macrophage were obtained from the American Type Culture
Collection (Rockville, MD). Cell monolayers were maintained at
less than 80% confluence in mammalian cell culture medium
(MCCM; Dulbecco’s Modified Eagles Medium containing 25 mM
glucose, 10% fetal bovine serum and 2 mM glutamine with/
without 50 mg/mL gentamicin). Exposures were conducted by
exposing mammalian cells to 10
2 to 10
6 cfu for zero to 24 h using
96-well cell culture plates (100 mL final). Some experiments
designed to study the effects of bacterial protein products included
the addition of a protease inhibitor cocktail (Complete
TM Tablets;
Roche Diagnotics, Penszberg, Germany) during Acinetobacter
exposure.
Table 1. Acinetobacter strains used in this study.
Bacterium ATCC # Abbrev.
Previous Genomospecies
Designation Biohazard Level*
Isolation Source of Strain as reported
by ATCC
A. baumannii 9955 Ab 2 2 Human spinal fluid
A. calcoaceticus 23055 Ac 1 2 Soil (Type Strain)
A. guillouiae 11171 Ag 11 1 Sewage containing gas-works effluent (Type
Strain)
A. haemolyticus 17906 Ah 4 2 Human sputum (Type Strain)
A. junii 17908 Aj 5 2 Human urine (Type Strain)
A. lwoffii 15309 Al 8/9 2 NA (Type Strain)
A. venetianus 31012 Av-RAG-1 NA 1 Tar on beach (Type Strain)
*Classified by ATCC according to U.S. Public Health Service guidelines.
NA – Not Available.
doi:10.1371/journal.pone.0037024.t001
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ogy were monitored by fluorescence and confocal microscopy. Cell
monolayers were pre-grown on glass coverslips, fixed for 5 min
with 4% (w/v) paraformaldehyde in PBS (pH 7.4), stained with
0.25% (v/v) SYTOX
TM green for 10 min, and for 5 min each
with 100 mg/mL Texas Red-conjugated wheat germ agglutinin
and rhodamine-phalloidin (1:40), according to the manufacture-
rs=procedures (Molecular Probes Inc, Eugene, OR). Results were
viewed and photographed with a Nikon TE-2000 Eclipse
microscope equipped with epifluorescence optics and either a
Nikon Coolpix 990 digital camera or a Nikon C1 confocal with
488, 543 and 633 lasers.
Quantitative changes in metabolism of mammalian cells during
bacterial exposure was monitored by measuring MTT bioreduc-
tion activity as described previously [37–38]. Following exposures,
the culture supernatants were removed and processed for cytokine
content as described in the next section. Fresh mammalian culture
media supplemented with MTT at a final concentration of one
mg/mL was added to the wells. The plates were incubated for two
hours at 37uC and the wells were rinsed twice with PBS to remove
non-adherent cells and bacteria. Following addition of 100 mL/
well DMSO (Sigma), solubilized-formazan color change was
measured at OD505. Bioreduction activity of exposed cells was
expressed as percentage activity compared to control PBS-treated
cells.
Cytokine Measurements
Cytokine activity was measured using supernatants from
individual exposures. Culture supernatants (100 mL) were trans-
ferred to membrane-containing 96-well (0.45 mm hydrophilic
Multiscreen
7 plates, Millipore Corp, Bedford, MA). The filtrates
were collected through a vacuum manifold into empty 96-well
plates. The bacteria and debris-free filtrates were frozen at 280uC
until further analysis for cytokine content. After thawing, levels of
IL-1b, IL-6, IL-8 and TNF-a were measured using a multiplex
liquid bead array assay (BioRad, Laboratories Inc., Mississauga,
ON), and validated using enzymatic immunosorbant assays [55]
with the following types of antibodies: capture antibodies, human
anti-IL-8 (4 mg/mL; R&D Systems, Minneapolis, MN), murine
anti-IL-1b (4 mg/ml), anti-IL-6 (0.5 mg/ml), anti-TNF-a (0.5 mg/
ml) (PeproTech, Rocky Hill, NJ); coating antibodies, biotinylated
anti-human IL-8 (20 ng/mL; R&D Systems), biotinylated anti-
murine IL-1b (100 ng/ml), anti-IL-6 (300 ng/ml), anti-TNF-a
(300 ng/ml; PeproTech). Recombinant IL-8 (R&D Systems), IL-
1b, IL-6, or TNF-a (PeproTech) were used as standards.
Lipopolysaccharide (LPS; 0.1 to 1.0 ng/mL) from Escherichia coli,
Salmonella typhimurium and Serratia marcescens (Sigma, Oakville, ON)
was used as a positive control for cytokine expression studies.
Macrophage Bactericidal Assay
Killing of bacteria by macrophage was tested using ,80%
confluent J774A.1 monolayers (,10
5 cells per 33 mm
2 well) and
10
3 bacteria in 100 mL of mammalian cell culture medium without
antibiotic. Several incubation times were tested and optimal
conditions were determined to be four hours at 37uC. Following
incubation, the entire well contents were scraped, serially diluted
in PBS and then plated on LB-agar. Colonies were enumerated
over a period of 18 to 72 h at 37uC. Control experiments included
wells with only bacteria, wells containing only J774A.1 with no
bacteria, and bacteria with HT29 epithelial cells.
PCR, Southern Hybridization and Sequencing
Primers for reported virulence factor genes (epsA and ompA;
[40][47][56] and the quinolone resistance determining regions
(QRDRs) of the constitutive genes parC and gyrA, where mutations
may confer fluoroquinolone resistance [57–60], were designed
from the Acinetobacter baumannii ATCC17978 genome. Primer
sequences were cross referenced to other complete Acinetobacter
genomes through Microbial Genomes Blast (http://www.ncbi.
nlm.nih.gov/sutils/genom_table.cgi) to ensure primers were not
strain specific (Table 2). Fragments were amplified from 100 ng of
genomic DNA template using standard reaction conditions
(AmpliTaq core reagents, ABI, Carlesbad, CA) with 0.6 mMo f
each primer and the following reaction parameters: 30 cycles
94uC, 15 sec; 50uC, 30 sec; 72uC, 1:30. PCR reactions were
fractionated by gel electrophoresis (1% agarose) and amplicons
were purified using a gel extraction spin kit (Qiagen, Germantown,
MD).
Genomic DNA (two mg) from each Acinetobacter strain was
digested with 10 units of EcoRI (New England BioLabs, Pickering,
ON) at 37uC for three hours followed by electrophoresis on (1%
agarose gels, 60 V, four hours). DNA contents of gels were pre-
treated (15 min acid depurination in 0.25 M HCl, 30 min
denaturation in 0.5 M NaOH, 1.5 M NaCl, 30 min neutralization
in 0.5 M NaCl, 1.5 M Tris HCl pH 7.5) before overnight transfer
onto Nytran supercharge nylon membranes (Whatmann, Piscat-
away, NJ) in 206SSC (3 M NaCl, 0.3 M sodium citrate, pH 7.0).
Purified Ab ompA and epsA PCR products were labelled with
32P-
dCTP using the Bioprime random labelling kit (GE Healthcare,
Baie d’Urfe, QC) and hybridized overnight to membranes at 42uC
in UltraHyb hybridization buffer (50% formamide) (Ambion,
Austin, TX). Blots were washed twice with 26SSC, 0.1% sodium
dodecyl sulphate (SDS) for 10 min at 42uC then twice with 0.56
SSC, 0.1% SDS for 15 min at 65uC. Membranes were exposed to
phosphorimager screens for two hours then scanned with the
Typhoon scanner (GEHealthcare, Baie d’Urfe, QC).
Amplicons of gyrA and parC were sequenced using BigDyeTer-
minator v3.1 sequencing kit (Applied Biosystems, Streetsville, ON)
and gene specific forward and reverse primers. Reactions were set
up with 1/8
th reaction mix, sequencing buffer, 0.5 mM primer and
50 ng PCR template. Reactions were purified using Centri-Sep
cycle sequencing clean up columns (Princeton Separations,
Adelphia, NJ). Sequencing reactions were run on an Applied
Biosystems 3130xl Genetic Analyzer on a 36 cm capillary array
using POP-7
TM polymer (Applied Biosystems, Streetsville, ON).
Sequences were assembled and translated using VectorNTI v11
software (Invitrogen, Carlsbad, CA).
Statistical Analysis
The significance of the differences in cytokines produced by
mammalian cells in response to different Acinetobacter strains was
done by comparing their levels with an analysis of variance
(ANOVA) followed by a post-hoc Tukey Multiple Comparison
Test. Statistical analyses were done with SigmaPlot software
(Systat Software Inc, San Jose, CA).
Results
Microbial Growth and Influence of Mammalian Cells
The proliferation capacity of the different Acinetobacter strains
was compared in a bacterial medium (LB) and mammalian cell
culture medium at 37uC. The results summarized in Table 3 are
derived from experiments using bioreduction of XTT as a sensitive
measure of bacterial growth and viability. In LB medium, the
majority of strains reduced XTT at low to high inoculation
concentrations. In contrast, almost all strains failed to reduce XTT
in mammalian cell culture medium at low seeding densities, aside
from Ah, which readily grew in all test conditions. Bioreduction
Virulence Potential of Acinetobacter Strains
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HT29 cells were present. The exception was Av-RAG-1, which
was highly bioreductive compared to all other strains in LB, but
showed the lowest bioreduction in mammalian cell culture
medium and no bioreduction in the presence of HT29 cells. A
similar assessment using macrophage-like J774A.1 cells was not
possible due to killing of most strains (see Section on Macrophage-
like J774A.1 Exposures).
Haemolytic Activity
The haemolytic potential of Acinetobacter strains was tested by
quantifying the lysis of sheep red blood cells embedded in agar
plates. All strains except Ac formed colonies within 24 h
(Figure 1A), but only Ah and Av-RAG-1 produced large clearing
zones, indicative of b-haemolysis comparable to that produced by
the B.cereus positive control. With longer incubations, Ac, Ag, and
Aj produced a weak response (a-haemolysis), beginning as faint
grey-green rings (Figure 1B, C and D), gradually forming a thin
clearing zone. No haemolytic activity (c-haemolysis) was produced
by Al colonies. The quantification of the haemolytic activity
summarized in Figure 1E was derived from four replicate plates by
comparing the diameters of the lytic zones (D2) with those of the
corresponding colonies (D1). Further tests of the filtrates derived
from 24 h cultures of these bacteria grown in nutrient broth
confirmed that only Ah and Av-RAG-1 produced appreciable
erythrocyte cytolysis (data not shown).
Mammalian Cell Toxicity
Loss of metabolism, measured by bioreduction of MTT, and
abnormal cell morphology were used as toxicity indicators for
assessing HT29 and J774A.1 exposures to bacteria cells and/or
their extracellular products. The data summarized in Figure 2A
show that all strains caused at least 15–20% loss in total HT29
bioreduction capacity within two hours of exposure. At this stage
there were no significant morphological changes other than
decreased intracellular formazan staining. With longer exposure
durations (18 h to 24 h), the most damaging strains were Ab and
Ah, causing 95% and 50% drops in bioreduction per well,
respectively.
Bacterial culture fractions of Ab were prepared to determine if
the toxicant was associated with the bacterial cell or was an
extracellular component. Cultures were separated into a bacterial
cell pellet fraction (P1), and cell-free, culture filtrate fraction (CF1)
by centrifugation and filtration. Figure 2B shows that when
exposures were done with P1 in the presence of the antibiotic,
gentamicin, HT29 metabolic loss and detachment were observed,
as reflected by the 65% drop in bioreduction. In contrast, CF1
exposure resulted in only ,20% bioreduction loss, and no cell
detachment. If the bacterial cultures were agitated prior to
filtration, the resultant filtrate (CF2) caused both toxicity and cell
detachment, suggesting that the effectors were loosely associated
with bacterial cell itself. Also, the toxic component of Ab was
resistant to heat (100uC, 30 min).
Compared to Ab and Ah, Av-RAG-1 was least toxic in
exposures to HT29 (Figure 2A). The diminished effects were
attributed to the inability of Av-RAG-1 to grow in the presence of
HT29 cells (Table 3). However, culture filtrates generated from
Av-RAG-1 cultures in LB, were haemolytic and also caused
,60% loss in bioreduction of HT29 cells (data not shown). This
toxic component was released into the medium during culture of
Av-RAG-1 without cell agitation prior to filtration.
Table 2. PCR Primers Used in this Study and Resulting Amplicon Sizes.
Gene Accession Forward Primer Reverse Primer PCR Amplicon/ORF Size(bp)
ompA AY485227 CGCTTCTGCTGGTGCTGAAT CGTGCAGTAGCGTTAGGGTA 531/1317
epsA NC_011595 AGCAAGTGGTTATCCAATCG ACCAGACTCACCCATTACAT 451/1101
gyrB CT025946.2 ATGAGCGTATCGGAAATCCG ACGTCAACAATACCTGATTTACC 485/2713
parC CU459141.1 GGCTGGTCTTCTTCACGAATA CCTTGCGCATCATGCGACAG 581/2220
doi:10.1371/journal.pone.0037024.t002
Table 3. Acinetobacter Growth-related Bioreduction Activity.
Test
Bacterium Optical Density of XTT-Formazan Produced at 24 h*
LB DMEM DMEM+HT29
10
2 cfu 10
4 cfu 10
6 cfu 10
2 cfu 10
4 cfu 10
6 cfu 10
2 cfu 10
4 cfu 10
6 cfu
Ab 0.4060.25 2.360.1 .3.2
{ 0.00 0.00 1.1460.02 0.00 1.1360.1 2.4260.19
Ac 0.0160.02 0.0160.01 0.6760.13 0.00 0.00 0.460.04 0.1160.01 0.2660.01 2.2860.27
Ag 0.00 0.0360.02 0.8960.05 0.00 0.00 0.1260.03 0.1860.03 0.2360.02 0.3360.14
Ah 1.5060.11 1.7360.16 2.1860.20 0.1260.08 1.2860.14 1.6360.14 0.6460.08 0.9260.11 1.4360.15
Aj 0.0460.06 0.0360.05 2.9560.14 0.00 0.00 1.4760.17 0.0860.01 0.4260.07 1.5760.16
Al 0.00 0.0360.02 1.5660.13 0.00 0.00 1.1460.15 0.2160.02 0.3060.05 1.5660.13
RAG-1 1.8560.08 2.3960.06 2.9260.06 0.00 0.00 0.5360.04 0.00 0.00 0.00
*Data represent means 6 standard deviation from six replicates.
{Upper Detection Limit of plate reader.
doi:10.1371/journal.pone.0037024.t003
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that the damage could be attributed to a combination of
diminished bioreduction capacity and numbers of attached
HT29 cells. To detail this observation further, exposed cells were
fixed and stained with dyes for the nucleus and fibrous actin
(Figures 2C and 2D), or membrane polysaccharides (Figures 2E
and 2F). Figures 2D and 2F show HT29 monolayers that were
disrupted by Ab and Ah exposures. These exposures were all done
at 18 h and not 24 h because very few HT29 remained attached at
the latter time point. Ab caused HT29 monolayers to detach in
entire sheets, whereas Ah caused individual cells to detach. In
either case, inclusion of a protease inhibitor cocktail during the
exposure prevented cell detachment. These inhibitors were neither
toxic to HT29 nor to the bacteria as measured by MTT and XTT
viability assays. However, microscopic examination of the wells
supplemented with protease inhibitors revealed that Ab and Ah
exposures still resulted in almost complete loss of HT29
intracellular bioreduction activity (ie., the cells exhibited no
internal formazan deposits). Cells incubated with bacteria showed
loss of actin-staining in Ab-exposed cells (Figure 2D) and wheat
germ agglutinin-binding in Ah-exposed cells (Figure 2F) compared
to corresponding unexposed controls (Figure 2C and 2E,
respectively). Also apparent during microscopy, was bacterial
adherence to the monolayer cells and surrounding well surfaces
Figure 1. Expression of haemolytic activity. Sheep blood agar plates were inoculated with 10
3 cfu/spot of each Acinetobacter species, and
photographed at 24 h (A), 48 h (B), 72 h (C) and 97 h (D). Graph (E) shows ratios of the diameters of the colonies with their lytic zones (D2) divided by
the diameters of the colonies only (D1). Data points are the means 6 standard deviation from 4 separate plate assays.
doi:10.1371/journal.pone.0037024.g001
Figure 2. Toxicity of Acinetobacter towards human colonic epithelial cells. (A) HT29 cell monolayers were exposed to 10
6 cfu/100 mL for up
to 24 h and analyzed for bioreduction activity as described in Materials and Methods. (B) Bioreduction activity of HT29 cells following a 24-h exposure
to Ab culture fractions in the presence of gentamicin. Bacterial cultures were centrifuged and separated into pellet (P1) and culture filtrate (CF1). The
pellet was resuspended in fresh media, vigorously agitated and recentrifuged to yield a secondary pellet (P2) and filtrate (CF2). (C–F) Confocal
micrographs of HT29 treated with PBS alone (C, E) or 10
6 cfu/100 mL of Ab (D) or Ah (E) for 18 h, and then fixed and permeabilized as described in the
Materials and Methods. Cells in C and D were stained with SYTOX
TM green and rhodamine-conjugated phalloidin. Panels E and F were stained with
SYTOX
TM green and Texas Red-conjugated wheat germ agglutinin. Error bars in A and B represent the mean of three exposures 6 standard deviation.
Bars in C–F represent 10 mm.
doi:10.1371/journal.pone.0037024.g002
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assays, which indicated that formazan contributed by bacteria was
highest in these exposures. Bacterial adherence was also demon-
strated with fluorescence from wheat germ agglutinin–bound Ah
(red stain in Figure 2F). The binding of lectins to the capsular
polysaccharide of one strain of A.venetianus has been documented
previously [61], but not for Av-RAG-1.
Phagocytosis and Macrophage Bactericidal Activity
The capacity of J774A.1 to phagocytize bacteria and prevent
infection in vitro, was examined using confocal microscopy, and
coupled with tests for bacterial cell viability during exposure.
Using the SYTOX
TM stain, cells of each bacterial strain were
initially detected on the apical surface of J774A.1 cells, but after
,5 min they were seen to internalize and migrate towards the
macrophage’s basolateral surface. The photo inset of Figure 3 is
typical of J774A.1 cells that have phagocytised Ah at the time of
maximal uptake (60 min).
Experiments were done to determine whether certain strains
had the ability to resist being killed by J774A.1. As shown in
Figure 3 with 4-h exposure assays, the viability of most Acinetobacter
strains was reduced by $80% when bacteria and macrophage
were co-incubated, compared to bacteria in mammalian cell
culture medium alone (or with HT29). The viability for most
strains was lowest whether their cell numbers were low (10
3 cfu/
100 mL) or high (10
4–10
6 cfu/100 mL well). However, Ah
consistently exhibited high viability, even at concentrations as
low as 10–100 cfu/100 mL. At higher concentrations, recovered
Ah cfu’s were greater than the initial seeding concentration.
Neither pre-activation of J774A.1 with IFN-c, nor longer co-
incubations of 7 to 24 h reduced Ah cfu numbers. Examination of
time-course experiments by microscopy and colony enumerations
revealed that the residual external bacteria were replicating, and
not the internalized bacteria. This observation suggested that the
surviving cfu=s measured in Figure 3 were primarily of external
origin.
In other experiments bacteria were co-incubated with J774A.1
in wells with a 0.2 mm filter barrier between them. This exposure
system resulted in no killing and demonstrated that phagocytosis
or close interaction was needed for J774A.1-induced killing to
occur. Parallel exposures conducted with HT29 epithelial cells did
not result in lowered viability.
Colonic Epithelial Cell Cytokine Production
Production of cytokines was monitored during exposures to
determine if Acinetobacter strains could initiate epithelial inflamma-
tory responses. Cytokine levels were quantified using multiplex
liquid bead arrays for GM-CSF, IL-1b, MIP-1b, IL-6, IL-8, IL-12
and TNF-a, and verified with double antibody sandwich
immunoassays. HT29 cells most consistently produced IL-8
during Acinetobacter exposures. Experiments with Ab and Ah
indicated that in the absence of antibiotic, the build-up of IL-8
peaked at 6–8 h and was markedly reduced thereafter. The
observed drop in levels was likely related to HT29 death and
detachment, but also IL-8 degradation during bacterial growth.
Inclusion of antibiotic throughout the exposure regime resulted in
sustained levels of ILB8 (Figure 4A). Unexposed HT29 produced a
low (constitutive) level of IL-8 in the supernatant. Exposure to
Acinetobacter strains in the presence of antibiotic resulted in
increased extracellular IL-8 levels which persisted for at least
48 h. The induced IL-8 production, measured by both multi-bead
array and ELISA, could be divided into two statistically divisible
groups (p,0.001 at 48 h). Strains of Ab, Ah, Aj and Av-RAG-1
induced between 1.7 and 3 fg IL-8 per HT29 cell, whereas Ac, Ag
and Al generated levels of #1 fg/cell.
Macrophage Cell Cytokine Production
Macrophage-like J774A.1 cells were tested for cytokine
production in exposures similar to those for HT29 cells. The
J774A.1 did not produce significant levels of neutrophil chemoat-
tractants, such as KC, but instead produced IL-1b, IL-6 and TNF-
a. These three cytokines are involved in the initiation of the acute
phase response (APR). In 24-h exposures with gentamicin, all
bacteria were strong inducers of the three cytokines, resulting in
extracellular expression levels of 0.3 fg/cell or 0.75 ng/mL for IL-
1b, 15 fg/cell or 38 ng/mL for IL-6 and 15 fg/cell or 38 ng/mL
for TNF-a (Figure 4B). The cytokine levels were comparable to
those produced by J774A.1 in control experiments using
commercial preparations of LPS (0.1 to 1.0 ng/mL) from
Escherichia coli, Salmonella typhimurium and Serratia marcescens.
Presence of Virulence-related Genes
To determine if the strains differed in genes that have been
reported to be overt toxins (espA (K1 capsular polysaccharide),
ompA (outer membrane protein A)) [25][47][56], primers targeting
those genes were made and used in PCR amplifications for
amplicon size comparisons. In all cases, the appropriate sized
amplicons were generated, suggesting that all the strains possessed
similar gene segments.
QRDR of gyrA and parC genes
To determine if the strains differed in the QRDRs, PCR and
nucleotide sequencing was carried out for the parC and gyrA genes.
Sequences translated in silico were aligned with strain Ab AYE,
known to have the amino acid substitution conferring resistance.
Sequences from all strains lacked the leucine residues associated
Figure 3. Phagocytosis and bactericidal activity of J774A.1
macrophage. Survival of bacteria was monitored by enumerating cfu’s
following 4-h incubation to 10
3 cfu/100 mL with or without monolayers
of J774A.1. Bacterial survival is expressed as the ratio cfu=s recovered
from incubations with J774A.1 in mammalian culture medium
(DMEM+supplements) and from mammalian culture medium alone.
Inset: Phagocytosis of bacteria (Ah shown as example) was monitored
by exposing J774A.1 monolayers to 10
6 cfu/100 mL for 60 min, and
then fixing and staining with SYTOX nucleic acid stain. Internalization
was visualized using a confocal microscope, and artificial graded colour
intensity (SYTOX intensity from blue to red) was used to highlight
bacteria (arrows) within J774A.1. Data points represent the means of
five separate experiments ; standard deviation. Bar represents 10 mm.
doi:10.1371/journal.pone.0037024.g003
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for parC).
Antibiotic Resistance
As a functional analysis of strain susceptibility towards a
fluoroquinolone antibiotic and also several other antibiotic classes,
bacterial MTT bioreduction activity towards a panel of antibiotics
was tested. Figure 6 shows the resulting antibiograms, which
clearly demonstrate that Ab was most resistant, albeit at low
antibiotic concentration, to some test antibiotics. Ag and Aj also
showed selective antibiotic resistance at low levels. Of these
antibiotics, ciprofloxacin is a secondary fluoroquinolone. None of
the strains showed high resistance to ciprofloxacin, which is
consistent with the sequencing results in Figure 5 showing absence
of mutations conveying fluoroquinolone resistance in genes, parC
and gyrA.
Discussion
This paper summarizes several in vitro bacterial and mammalian
cell-based assays that permit differentiation between potentially
hazardous or virulent Acinetobacter strains from relatively safe
strains. The assays that were useful in discriminating the virulence
of these bacterial strains are summarized in Table 4. As we have
cautioned for other genera [62], broad species-level conclusions
should not be generalized from the test strains examined here. The
analyses conducted would need to be repeated for each strain
under evaluation.
In initial experiments, we screened strains for their capacity to
multiply or grow in mammalian cell culture medium at 37uCa sa
simple determinant of potential virulence. In previous studies of
the B.cereus-group bacteria, XTT bioreduction was used to
measure growth of each strain in culture media alone or in the
presence of mammalian cells [53]. In preliminary studies we found
that the rates of XTT reduction by the different Acinetobacter strains
Figure 4. Mammalian cell inflammatory cytokine levels during exposure to test bacteria. HT29 (A) and J774A.1 (B) cells were exposed to
10
6 cfu/100 mL test bacteria for various time intervals. Exposure supernatants were filtered and used in liquid array bead assays for IL-8 (A) or IL-1b, IL-
6 and TNF-a (B). Experiments were reproduced twice using both the multiplex liquid bead assay and ELISA, both yielding results within 15%
variability of each other. Data points are means of three exposures ; standard deviation.
doi:10.1371/journal.pone.0037024.g004
Figure 5. Alignment of Quinolone Resistance Determining Regions. ClustalW alignment of coding regions of gyrA (A) and parC (B) genes
derived from test Acinetobacter strains compared to Ab AYE strain with known fluoroquinolone resistance mutations. The alignment demonstrates
that the test strains lack a Ser-Leu transition necessary for fluoroquinolone resistance.
doi:10.1371/journal.pone.0037024.g005
Virulence Potential of Acinetobacter Strains
PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e37024were similar in LB medium, but lower than the previously
observed rates of Bacillus spp by ,4–5 times. However, similar to
the Bacilli, most of the Acinetobacter strains were unable to grow or
grew poorly in mammalian cell culture medium at the lowest
inoculation concentrations, unless supplemented with either
mammalian cells or mammalian cell-conditioned medium (data
not shown). The exception was the Ah strain, which grew well,
with or without HT29 cells. In contrast, Av-RAG-1 did not grow
well in mammalian culture medium even in the presence of HT29
or conditioned medium.
Another indicator of virulence is the production of toxic or lytic
by-products by various strains. In experiments using the sheep
blood agar plate assay, both Ah and Av-RAG-1 exhibited strong
haemolytic activity (referred to as b-haemolysis) whereas all other
strains exhibited weak (a- haemolysis) or no (c-haemolysis)
capacity. However, Av-RAG-1 was not able to grow in
mammalian medium in absence or presence of HT29 like other
strains. Our data match that of several other reports in that only
Ah and Av-RAG-1 were haemolytic [63–66]. However, none of
these studies described the haemolysis in a semi-quantitative
manner, as we have done here. In another study, 526 Acinetobacter
strains were tested for haemolytic activity with human, sheep and
bovine erythrocytes, and only 16% of them exhibited b-haemolysis
while the majority were a-haemolytic [51]. This study included 24
Ah strains of which 17 (70%) were b-haemolytic. Some of the
strains used by Gospodarek et al [51] may have been misclassified
or variable in expression of haemolytic acivity since an absence of
haemolytic activity was seen in 20 nosocomial Ab isolates tested
with rabbit erythrocytes [41]. Furthermore, Antunes and col-
leagues [50] have recently demonstrated that there is significant
inter-strain variation in the haemolytic capacity of four different
Ab isolates, which is also dependent on the source (horse or sheep)
of blood used in the assays. The genetic factor(s) contributing to
this haemolytic activity remains to be identified.
As a further screen for toxic and lytic products, we used two
mammalian cell models. In exposures using the colonic epithelial
HT29 bioreduction assay [37], toxicity ensued rapidly within two
hours of exposure most notably for Ab and Ah compared to the
other strains. Further studies showed that loss of mammalian cell
Figure 6. Antibiotic Susceptibility Assays. Antibiograms generated from growing each Acinetobacter strain in trypticase soy broth in the
presence of different concentrations and classes of antibiotics for durations and temperatures indicated in the figure. The minimum inhibitory
concentration (MIC) is the lowest concentration that is effective in preventing bacterial MTT bioreducton. Data are means of four experiments with
vertical bars indicating standard deviation.
doi:10.1371/journal.pone.0037024.g006
Table 4. Summary of Assays for Comparing Potential
Virulence Characteristics of Acinetobacter.
Pathogenic Characteristic* Ab Ac Ag Ah Aj Al
Av-RAG-
1
Bacterial Growth with Mammalian
Cells
++(+) +++2
Haemolytic Activity (+)( +)( +) + (+) 2 +
Mammalian Cell Detachment/Lysis + (+)( +) + (+)( +)( +)
Bacterial Survival with J774A.1 2 (+) 2 + (+) 2 (+)
HT29 Neutrophil Chemoattractant
(IL-8)
(+) 22++2 +
Growth with Antibiotics** + 2 + (+) + (+)( +)
+ signifies substantial growth or activity.
(+) signifies low level and/or delayed activity.
2 signifies negligible growth or activity
*Note that tests for induction of J774A.1 pro-inflammatory cytokines (IL-1b, Il-6,
TNF-a) and presence of known virulence gene segments (OmpA, EpsA) were
excluded from the summary table since they failed to discriminate between
bacterial strains.
**Growth for this purpose is defined as MTT bioreduction in the presence of at
least 5 mg/mL antibiotic.
doi:10.1371/journal.pone.0037024.t004
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adherence, which would have contributed to total MTT formazan
measured per assay well. With crude fractionation, it was shown
that the Ab-mediated detachment of HT29 monolayers was cell
wall -associated, likely proteinaceous and could be the same
component causing the loss of HT29 bioreduction capacity. In
contrast, the toxic agent(s) of Ah was not necessarily associated
with the bacterial cell, since bacteria-free culture filtrates also
caused hemolysis and cytolysis. Furthermore, while Av-RAG-1 did
not grow in presence or absence of HT29 it did produce an Ah-
like, filterable, extracellular-cytotoxic activity (as well as haemo-
lytic activity) when grown in LB broth. This activity was heat
sensitive, whereas the Ab toxicant was not. [63–66]
Several studies have identified cytotoxic factors from various Ab
strains. In particular, Ab produces outer membrane vesicles that
contain a number of virulence-related factors [67]. One of these
factors, Ab outer membrane protein A (AbOmpA), is suggested to
play an important role in pathogenesis as evidenced by its
pleiotropic effects. Purified AbOmpA was localized to the
mitochondria of HEp-2 human laryngeal epithelial cells, and
resulted in the release of pro-apoptotic molecules such as
cytochrome c and apoptosis-inducing factor into the cytosol,
caspase-3 activation, and DNA fragmentation [56]. None of our
strains demonstrated a difference in the presence of genes for ompA
or another reported virulence factor gene, epsA. Our studies used
the same Ab strain as in previous work of Choi and colleagues
[40], and yet we did not observe Ab invasion of HT29 colonic
epithelial cells, supporting earlier observations that other cell types
were not as permissive for invasion as respiratory epithelial cells.
Comparison of wild-type and AbOmpA-negative isogenic mutants
of Ab by Choi et al [40] demonstrated that AbOmpA was also
involved in epithelial cell attachment, which we have observed
during our studies.
Since there are concerns about antibiotic resistance of some
Acinetobacter strains [68–70], we also tested inhibitory effects (MIC
assay) of several antibiotics, and in particular, if the test strains
carry known mutations in the constitutive genes gyrA and parC
conferring fluoroquinolone resistance [57–58]. The genes for gyrA
and parC were sequenced, and then translated and aligned in silico.
None of the tested strains had the serine to leucine transition (gyrA
codon 83 and/or parC codon 80 or 84) implicated in the
fluoroquinolone resistance phenotype (Figures 5A and 5B).
Functional susceptibility to fluoroquinolone was confirmed for all
strains with an MIC assay. Furthermore, this assay demonstrated
that the Ab strain exhibited the most resistance to the antibiotics in
general, and the least effective antibiotics towards all strains were
cefotaxime, ceftazidime, and trimethoprim. The MIC assay also
revealed that none of the strains were resistant to the fluoroquin-
olone, ciprofloxacin.
As a measure of immune response, we screened for bacterial-
induced release of select cytokines known to be associated with our
mammalian cell models [39]. For HT29, all of the Acinetobacter
strains induced IL-8 levels that were consistent with those recorded
for other non-invasive bacteria [71]. This neutrophil chemoat-
tractant has been used previously to differentiate between
pathogens and generally harmless bacteria [71–74]. The present
study showed that Ab induced less IL-8 production in HT29 cells,
compared to Aj, Ah, and RAG-1. Our results agree with a recent
study by de Breij and colleagues [1] who reported that human
epithelial cells produced less IL-8 in response to A. baumannii strains
than to A. junii strains. They also suggested that A. baumannii
appeared to be more virulent compared to the other strains, since
infection caused by A. baumannii was associated with reduced
capacity of bacterial elimination from the host. Furthermore, we
agree with their comment that outgrowth may have caused
increased elevation of the cytokines, as we see substantial growth
in the presence of HT29 cells over a 24-h period (Table 3).
However, our cytokine experiments were done in the presence of
antibiotic to avoid the effect of differential growth on cytokine
production, but also to limit any cytotoxicity associated with
proliferating bacteria.
In contrast to the high levels of HT29 IL-8 release, J774A.1
released several pro-inflammatory cytokines, but none which were
useful for differentiating between the strains tested. The similarity
in the levels of J774A.1 cytokines, regardless of test bacterial strain,
is consistent with known mechanisms of macrophage receptor-
mediated recognition of bacterial pathogens. That is, cytokine
induction is largely a result of pathogen-associated molecular
patterns (PAMPs) made up of well-conserved microbial surface
moieties, such as LPS or peptidoglycan (see reviews: [75–78].
Huttunen and colleagues [79] have used IL-1b, IL-6, and TNF-
a expression from RAW264.7 macrophage as toxicological
indicators of hazard from indoor microbial sources. In their
study, doses up to 10
7 cfu/mL (equivalent to our 10
6 cfu/100 mL
well), caused different levels of acute phase response (APR)
cytokines depending on the bacterial strain tested. Bacillus cereus
was least inducing (eg. 3.1 ng/mL TNFa), Streptomyces californicus
caused an intermediate level (6.1 ng/mL TNF-a) and Pseudomonas
fluorescens was marginally better (6.9 ng/mL TNF-a). In prelimi-
nary comparative tests (data not shown), we found that when the
macrophage-like cell line RAW264.7 was exposed to Acinetobacter
strains, it expressed APR cytokines at similar levels as J774A.1.
However, those levels were at least 5-fold higher than those
observed by Huttunen and colleagues with the RAW264.7 cells.
The difference is most probably due to macrophage densities
during exposure, underlining the importance of expressing
cytokine expression data on a per-cell basis. In addition, bacterial
species or strain differences likely play a role in the differential
APR cytokine expression levels observed here. The lack of a
difference we observed with our test system suggests that APR
cytokine expression is not discriminatory at the species level for
Acinetobacter, but may be a more relevant indicator when
comparing between genera.
Our data with J774A.1 cells clearly demonstrate that Ah is the
most resistant to macrophage-induced inactivation. Unlike other
claims that addition of 0.004–0.1% Triton X-100 facilitates release
of internalized bacteria and improves colony recovery [80], we
found that the detergent was ineffective between 0.004–0.05% in
lysing J774A.1 cells, and inhibited bacterial growth above 0.05%.
In conclusion, this comparative study shows the utility of in vitro
assays and molecular probes for assessing for growth, toxicity,
infectivity and potential immune responses to aid in screening
virulence potential of select Acinetobacter species or strains.
Collectively, these analyses have demonstrated that the Ab and
Ah strains used here are likely to be the most hazardous if used in a
biotech process involving large scale release. In contrast, the
environmental strain Ag was relatively benign for growth in
mammalian environments, toxicity and intracellular infectivity.
Further, the Av-RAG-1 bioremediation strain was relatively non-
infectious, but it had strong haemolytic capacity and induced
production of inflammatory chemokines. These observations
suggest that Av-RAG-1 should be investigated in more detail for
potential clinical effects prior to environmental use as an
industrial-scale bioremediation agent. Furthermore, our results
suggest that ompA and epsA are not the primary virulence factors
for these test stains. The next phase of our research will focus on
confirming these in vitro observations using analogous in vivo
Virulence Potential of Acinetobacter Strains
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Bacillus organisms [39].
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